Literature DB >> 14600607

Metastatic disease of the spine: evaluation and treatment.

Matthew P Walker1, Michael J Yaszemski, Choll W Kim, Robert Talac, Bradford L Currier.   

Abstract

Treatment of patients with metastatic disease of the spine continues to be a challenging problem. Advances in imaging studies and surgical techniques have improved patient outcomes with operative intervention. However, the lack of a validated set of criteria to determine spinal instability makes patient selection for surgical intervention difficult. Multiple classification systems that assist surgeons in determining appropriate operative candidates have been proposed. We will review current information on the evaluation and treatment of metastatic disease of the spine and discuss classification systems that assist in determining appropriate operative candidates.

Entities:  

Mesh:

Year:  2003        PMID: 14600607     DOI: 10.1097/01.blo.0000092977.12414.f9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  17 in total

1.  Which MR imaging sequences are necessary in determining the need for radiation therapy for cord compression? A prospective study.

Authors:  A J Johnson; J Ying; T El Gammal; R D Timmerman; R Y Kim; B Littenberg
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

2.  Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.

Authors:  R Kreienberg; U-S Albert; M Follmann; I B Kopp; T Kühn; A Wöckel
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-06       Impact factor: 2.915

3.  Combined radiofrequency and kyphoplasty in painful osteolytic metastases to vertebral bodies.

Authors:  A Sandri; G Carbognin; D Regis; D Gaspari; C Calciolari; V Girardi; G Mansueto; P Bartolozzi
Journal:  Radiol Med       Date:  2009-08-07       Impact factor: 3.469

4.  Clinical outcome of posterior fixation surgery in patients with vertebral metastasis of lung cancer.

Authors:  Tomoyuki Igarashi; Keigo Okamoto; Koji Teramoto; Ryosuke Kaku; Keiko Ishida; Keiko Ueda; Yo Kawaguchi; Tetsuo Hori; Masayuki Hashimoto; Shoji Kitamura; Noriaki Tezuka; Jun Hanaoka
Journal:  Mol Clin Oncol       Date:  2017-03-17

5.  Predictive value of seven preoperative prognostic scoring systems for spinal metastases.

Authors:  Andreas Leithner; Roman Radl; Gerald Gruber; Markus Hochegger; Katharina Leithner; Heike Welkerling; Peter Rehak; Reinhard Windhager
Journal:  Eur Spine J       Date:  2008-09-12       Impact factor: 3.134

6.  DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC).

Authors:  Rainer Souchon; Frederik Wenz; Felix Sedlmayer; Wilfried Budach; Jürgen Dunst; Petra Feyer; Wulf Haase; Wolfgang Harms; Marie-Luise Sautter-Bihl; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

7.  Percutaneous cementoplasty in multiple myeloma: a valuable adjunct for pain control and ambulation maintenance.

Authors:  Nhu Nam Tran Thang; German Abdo; Jean-Baptiste Martin; Yodit Seium-Neberay; Hasan Yilmaz; Marie-Christine Verbist; Daniel Rufenacht; Andre-Pascal Sappino; Pierre-Yves Dietrich
Journal:  Support Care Cancer       Date:  2007-10-25       Impact factor: 3.603

8.  Predictors of survival in surgically treated patients of spinal metastasis.

Authors:  Pravin Padalkar; Benjamin Tow
Journal:  Indian J Orthop       Date:  2011-07       Impact factor: 1.251

9.  Minimally invasive treatment of spinal metastases: techniques.

Authors:  Peter S Rose; Michelle J Clarke; Mark B Dekutoski
Journal:  Int J Surg Oncol       Date:  2011-06-28

10.  CORR Insights®: Radiation Disrupts Protective Function of the Spinal Meninges in a Mouse Model of Tumor-induced Spinal Cord Compression.

Authors:  Timothy A Damron
Journal:  Clin Orthop Relat Res       Date:  2021-01-01       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.